These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 18183530)

  • 41. [Does 'selective binding profile' result in 'selective treatment'?].
    Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):1-5. PubMed ID: 11400320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology of schizophrenia and the role of newer antipsychotics.
    Risch SC
    Pharmacotherapy; 1996; 16(1 Pt 2):11-4. PubMed ID: 8778681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic possibilities of cysteamine in the treatment of schizophrenia.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):199-202. PubMed ID: 17166669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New perspectives on biological treatment of schizophrenia.
    Lingjaerde O
    Acta Psychiatr Scand Suppl; 1994; 384():102-7. PubMed ID: 7879631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular risks of atypical antipsychotic drug treatment.
    Drici MD; Priori S
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Influences of second generation antipsychotics on the course of schizophrenia].
    Messer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S161-3. PubMed ID: 15570540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment.
    Remington G; Agid O; Foussias G
    Expert Rev Neurother; 2011 Apr; 11(4):589-607. PubMed ID: 21469931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What's atypical about atypical antipsychotic drugs?
    Meltzer HY
    Curr Opin Pharmacol; 2004 Feb; 4(1):53-7. PubMed ID: 15018839
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Schizophrenia: moving beyond monoamine antagonists.
    Conn PJ; Tamminga C; Schoepp DD; Lindsley C
    Mol Interv; 2008 Apr; 8(2):99-107. PubMed ID: 18403654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles.
    Nasrallah HA
    Mol Psychiatry; 2008 Jan; 13(1):27-35. PubMed ID: 17848919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Strategy for modulation of central dopamine transmission based on the partial agonist concept in schizophrenia therapy.
    Inoue A; Nakata Y
    Jpn J Pharmacol; 2001 Aug; 86(4):376-80. PubMed ID: 11569610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia.
    Heresco-Levy U
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):827-44. PubMed ID: 16262565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the serotonin transporter in lymphocytes and platelets of schizophrenia patients treated with atypical or typical antipsychotics compared to healthy individuals.
    Barkan T; Peled A; Modai I; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2006 Aug; 16(6):429-36. PubMed ID: 16431091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurobiological background for the development of new drugs in schizophrenia.
    López-Muñoz F; Álamo C
    Clin Neuropharmacol; 2011; 34(3):111-26. PubMed ID: 21586917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of antipsychotics in first line].
    Stefos G
    Rev Med Brux; 2004 Sep; 25(4):A302-7. PubMed ID: 15516061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sexual dysfunction in schizophrenia: focus on recent evidence.
    Baggaley M
    Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.